Pharma Strategy: Loss of Exclusivity (LOE) (PowerPoint PPT Slide Deck)

HEALTHCARE PPT DESCRIPTION

Loss of Exclusivity (LOE) pharma strategy PPT: Learn how to manage patent expiry, generic competition, and maximize product value. Download this expert presentation now. Pharma: Loss of Exclusivity (LoE) is a 25-slide PPT PowerPoint presentation slide deck (PPT) available for immediate download upon purchase.

Explore Slides inside the Deck:

Strategies for Launching Generic Pharmaceuticals Strategies for Maximizing Brand Value Post-Patent Strategic Timeline for Managing Loss of Exclusivity

Expiration of a drug patent means end of the branded drug value and revenue stream for a majority of pharmaceutical firms. This loss of exclusivity (LOE) puts to risk a huge amount of money in global pharmaceutical sales.

LOE certainly brings about a steep decline in a drug sales. A brand's unit share declines to about 16% by the time generics arrive and play in the market for a year. However, this is not a "game over" scenario.

This deck discusses 3 key strategies to preserve value for the brands after patent expiration:

1. Preserve Brand Equity and Patient Loyalty
2. Develop an Over-the-Counter (OTC) Version
3. Launch a Generic Version

No matter which LOE strategy a company selects to maintain product revenue, early action and execution is critical.

LOE is part of the different phases of a product's lifecycle and should be strategically thought out and managed. The presentation also highlights other avenues to tap revenue opportunities besides extending a drug's patent life through reformulations and introducing new indications.

The slide deck also includes some slide templates for you to use in your own business presentations.

The PPT provides a comprehensive guide on managing the critical phase of Loss of Exclusivity (LOE) in the pharmaceutical industry. It emphasizes the importance of early planning and execution to mitigate the impact on revenue streams. The strategies outlined are not just theoretical, but are backed by practical templates and checklists to facilitate implementation.

The presentation also delves into the nuances of brand affinity and market dynamics, offering insights into how these factors influence the choice of LOE strategy. It includes a detailed timeline for planning and executing LOE strategies, ensuring that companies can navigate this challenging phase with precision and foresight. This resource is indispensable for pharmaceutical executives aiming to sustain brand value and revenue post-patent expiry.

Got a question about this document? Email us at [e-mail].

HEALTHCARE PPT SLIDES

Strategies for Launching Generic Pharmaceuticals

This PPT slide outlines a strategic approach for pharmaceutical companies to launch generic products in response to low-cost alternatives. It presents 3 methods: Branded Generic, Authorized Generic, and Licensed Generic. The Branded Generic approach utilizes existing supplies to create a generic version that retains brand identity, appealing to cost-sensitive customers. The Authorized Generic strategy leverages current manufacturing capabilities to produce a private-label version, expanding market reach through partnerships. The Licensed Generic method involves collaborating with competitors to develop a generic product, facilitating earlier market entry, which is critical for capturing market share. Timing is essential, especially when generic competitors have established a presence. The effectiveness of these strategies increases when fewer than 5 generic entrants are in the market.

Strategies for Maximizing Brand Value Post-Patent

This PPT slide outlines 3 strategies for pharmaceutical companies to maximize brand value post-loss of exclusivity (LOE). Proactive planning is essential to capitalize on revenue opportunities after patent expiration. The first strategy focuses on preserving brand equity and patient loyalty through enhanced patient acquisition and retention efforts. The second strategy involves developing an over-the-counter (OTC) version of the drug to slow brand value erosion and capture a different market segment. The third strategy is launching a generic version of the drug, allowing companies to profit from patients who switch to generics. These strategies have been effectively implemented by major pharmaceutical companies like Pfizer and AstraZeneca, providing flexibility in execution.

Strategic Timeline for Managing Loss of Exclusivity

Planning for Loss of Exclusivity (LOE) in the pharmaceutical sector is critical, requiring companies to initiate strategies at least 2 years prior to patent expiry. Delaying action until the LOE date can result in missed opportunities to optimize market position and product value. The LOE planning timeline is divided into 3 phases: Pre-LOE (2 years before LOE, focusing on foundational strategies), Peri-LOE (1 year encompassing the 6 months before and after LOE, emphasizing agile responses), and Post-LOE (1 year after LOE, implementing strategies to sustain brand value and revenue). Meticulous planning is essential for effective strategy execution in navigating patent expirations.

Strategic Approach to Product Lifecycle Management

The "Sunset the Brand" strategy is relevant for firms losing exclusivity in product offerings. It involves a strategic reduction of Stock Keeping Units (SKUs) based on tailored evaluations of expenditures and inventory management while maintaining manufacturing. The timing of the sunsetting process is influenced by market dynamics and the presence of generic competitors, which can accelerate the need for action. Companies must manage their product portfolio effectively, ensuring efficient resource allocation while maintaining market presence. This approach requires a nuanced understanding of internal cost structures and external market conditions, essential for navigating product lifecycle management in a competitive environment. The sunsetting strategy provides a structured pathway to mitigate losses and optimize resource allocation during market transitions.

Strategic Options for LOE Based on Brand Affinity

This PPT slide presents a strategic framework for Loss of Exclusivity (LOE) management in the pharmaceutical sector, focusing on brand affinity. For high brand affinity, preserving brand value and considering over-the-counter (OTC) options is essential. Evaluating FDA approval criteria determines the feasibility of switching to OTC strategies; a positive outcome supports both branded and OTC approaches, while a negative response necessitates reinforcing the branded strategy. Firms lacking exclusivity may struggle with OTC revenue due to diminished market differentiation. For low brand affinity, launching a generic product or sun-setting the brand are viable strategies. A generic launch requires significant resources and speed to market, with securing contracts with distributors and wholesalers being crucial for market share. The decision to pursue an LOE strategy should consider internal capabilities and long-term potential in the generics market.

Source: Best Practices in Pharma Industry PowerPoint Slides: Pharma Strategy: Loss of Exclusivity (LOE) PowerPoint (PPT) Presentation Slide Deck, LearnPPT Consulting